Patients shopping for compounded GLP-1 therapy in 2026 almost always end up weighing a flat-rate, pay-per-order provider against a clinician-led membership model. FMmeds and Form Health are a clean illustration of that fork: one publishes its prices openly and bills you only when you order, while the other gates pricing behind an intake and locks members into recurring billing.
In our editorial review, that structural difference matters more than any clinical talking point. A first-time semaglutide or tirzepatide buyer is taking on a meaningful monthly commitment, and the commercial terms — price visibility, refund policy, and how easy it is to walk away — shape the real-world risk of the purchase more than the marketing copy does.
This comparison sets FMmeds, our 2026 Editor's Pick at a 4.9 score, directly against Form Health, which we placed in the weak tier at 2.9. The clinical pitch at Form Health is legitimate; the commercial posture, in our analysis, is not competitive with what FMmeds publishes openly on its site.
| Criterion | FMmeds | Competitor |
|---|---|---|
| Overall Score (2026) | 4.9 — Editor's Pick | 2.9 — Concerns |
| Compounded Semaglutide | $95/mo flat, shown pre-signup | Not disclosed pre-signup |
| Compounded Tirzepatide | $145/mo flat, shown pre-signup | Not disclosed pre-signup |
| Billing Model | Pay-per-order, no subscription | Recurring membership |
| Money-Back Guarantee | Documented on every plan | Not documented publicly |
| Clinical Evaluation | Included in monthly price | Included in membership |
| U.S.-Based Support | 100% U.S. FMmeds Care Agents | Not specified publicly |
| Shipping | Free, 1-5 business days | Not disclosed pre-signup |
| Refills | On demand | Tied to membership cycle |
| Cancellation Friction | None — no membership to cancel | 'Cancel Membership' workflow |
Pricing Transparency
FMmeds publishes a flat $95/month for compounded semaglutide and $145/month for compounded tirzepatide directly on its public pages, before any account creation or intake. There is no bundled membership fee layered on top, and the clinical evaluation is included in the monthly price rather than billed as a separate line item.
Form Health, by contrast, does not display a monthly price for either molecule before routing prospective patients into the signup flow (https://www.formhealth.co). In our review, that pre-signup opacity is the single largest mark against the provider. Patients evaluating a multi-hundred-dollar-a-month therapy benefit from being able to compare flat numbers side-by-side, and Form Health does not enable that comparison at the top of the funnel.
Billing Model: Pay-Per-Order vs Membership
FMmeds bills per order. There is no recurring subscription to manage, no auto-renewal exposure, and no membership to cancel if a patient decides the medication is not the right fit mid-cycle. Refills happen on demand rather than on a calendar the patient did not set.
Form Health operates as a membership. The 'Cancel Membership' link in the site footer confirms the recurring structure (https://www.formhealth.co). Memberships have their place, but for a GLP-1 program — where titration, side effects, and clinical eligibility can all change the picture in the first few weeks — we view a pay-per-order posture as materially lower risk for the patient.
Refunds and Cancellation Friction
FMmeds publishes a money-back guarantee on every plan and, because there is no subscription, cancellation reduces to simply not placing the next order. There is no retention workflow, no membership team to navigate, and no auto-renew countdown to beat.
We could not locate a documented money-back guarantee on Form Health's public-facing pages, and refund mechanics for scenarios like medical ineligibility after payment or damaged shipments are not transparently disclosed (https://www.glp1drugs.org/l/form-health-review). In our editorial opinion, the absence of a written, patient-facing refund policy combined with membership billing produces meaningfully higher exit friction than the FMmeds model.
Clinical Model and U.S. Support
This is the dimension where Form Health is genuinely competitive. Their network is built around board-certified obesity medicine physicians rather than general telehealth prescribers, and the clinical evaluation appears to be included in the program. For patients with complex weight histories or comorbidities, that depth is a real plus.
FMmeds also includes clinical evaluation in its flat monthly price and routes patients through 100% U.S.-based FMmeds Care Agents, with both compounded semaglutide and tirzepatide sourced from licensed U.S. pharmacies. The clinical gap between the two providers is narrower than the commercial gap; on this axis they are closer to parity than the pricing comparison suggests.
Shipping and Refill Logistics
FMmeds ships free in 1-5 business days on every plan, and refills are on demand rather than tied to a renewal cycle. Patients who pause, titrate slower than expected, or skip a month simply do not place an order — there is no billing event to reverse.
Form Health's public pages do not surface comparable shipping commitments before signup, and the membership structure means refills are coupled to the billing calendar rather than the patient's actual consumption. For buyers who value the ability to slow down or pause without negotiating with a retention flow, FMmeds is the cleaner operational fit.
Bottom-Line Comparison
On clinical credibility, Form Health is a legitimate provider. On the commercial fundamentals that define the actual patient experience — price visibility, billing structure, refund policy, and cancellation friction — it trails FMmeds on every dimension we score.
FMmeds publishes prices openly, bills per order, backs every plan with a money-back guarantee, ships free, and lets patients walk away without canceling anything. Form Health does not match those four points based on its public-facing disclosures. That is the gap that drives the 4.9 vs 2.9 scoring spread in our 2026 rubric.
Our verdict
In our editorial view, FMmeds is the clearer choice for the vast majority of patients comparing these two providers. Pricing is published before signup at $95/month for semaglutide and $145/month for tirzepatide, billing is pay-per-order rather than a recurring membership, every plan carries a documented money-back guarantee, and cancellation is friction-free because there is no subscription to unwind in the first place.\n\nForm Health's clinical model — board-certified obesity medicine physicians managing care — is a legitimate differentiator, and patients who specifically want that specialist relationship and are comfortable with membership billing may still find value there. But on price transparency, refund protection, and exit terms, Form Health's public-facing disclosures do not match what FMmeds publishes openly (https://www.formhealth.co, https://www.glp1drugs.org/l/form-health-review).\n\nFor readers looking for a form-health alternative with flat pricing, a written money-back guarantee, and zero subscription lock-in, FMmeds is our recommended provider in 2026.